These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 3370916)
1. Inhibition of platelet aggregation and thromboxane production by low concentrations of aspirin in vitro. Sils D; Rodgers SE; Lloyd JV; Wilson KM; Siebert DM; Bochner F Clin Sci (Lond); 1988 May; 74(5):491-7. PubMed ID: 3370916 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. De Caterina R; Giannessi D; Gazzetti P; Bernini W Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876 [No Abstract] [Full Text] [Related]
3. Effect of aspirin infusions on platelet function in humans. Wilson KM; Siebert DM; Duncan EM; Somogyi AA; Lloyd JV; Bochner F Clin Sci (Lond); 1990 Jul; 79(1):37-42. PubMed ID: 2167788 [TBL] [Abstract][Full Text] [Related]
4. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188 [TBL] [Abstract][Full Text] [Related]
5. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043 [TBL] [Abstract][Full Text] [Related]
6. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384 [TBL] [Abstract][Full Text] [Related]
8. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Hanley SP; Bevan J; Cockbill SR; Heptinstall S Lancet; 1981 May; 1(8227):969-71. PubMed ID: 6112387 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness--a multiparametric study in rats. Nocun M; Golanski J; Lapshina E; Zavodnik L; Dobaczewski M; Kazmierczak P; Markuszewski L; Zavodnik I; Watala C Clin Chem Lab Med; 2006; 44(7):853-62. PubMed ID: 16776633 [TBL] [Abstract][Full Text] [Related]
10. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release. Mikhailidis DP; Jeremy JY; Barradas MA; Green N; Dandona P Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1495-8. PubMed ID: 6416473 [TBL] [Abstract][Full Text] [Related]
12. Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man. Böger RH; Bode-Böger SM; Gutzki FM; Tsikas D; Weskott HP; Frölich JC Clin Sci (Lond); 1993 May; 84(5):517-24. PubMed ID: 8504628 [TBL] [Abstract][Full Text] [Related]
13. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects. Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329 [TBL] [Abstract][Full Text] [Related]
14. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man. Lorenz R; Siess W; Weber PC Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575 [TBL] [Abstract][Full Text] [Related]
15. Dose-dependent inhibition of phosphoinositide metabolism in human platelets by aspirin in vitro and in vivo. Godfrey PP; Bochner F; Grahame-Smith DG Br J Clin Pharmacol; 1986 Oct; 22(4):443-7. PubMed ID: 3021189 [TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro. Bode-Böger SM; Böger RH; Galland A; Frölich JC Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487 [TBL] [Abstract][Full Text] [Related]
17. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy. Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542 [TBL] [Abstract][Full Text] [Related]
18. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358 [TBL] [Abstract][Full Text] [Related]